These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25230947)

  • 1. Republished: new age of biological therapies in paediatric rheumatology.
    Sen ES; Ramanan AV
    Postgrad Med J; 2014 Oct; 90(1068):590-6. PubMed ID: 25230947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New age of biological therapies in paediatric rheumatology.
    Sen ES; Ramanan AV
    Arch Dis Child; 2014 Jul; 99(7):679-85. PubMed ID: 24621445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):151-6. PubMed ID: 19770495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
    Ruperto N; Martini A
    Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New advances in the management of juvenile idiopathic arthritis--1: non-biological therapy.
    Beresford MW; Baildam EM
    Arch Dis Child Educ Pract Ed; 2009 Oct; 94(5):144-50. PubMed ID: 19770494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the European paediatric legislation in paediatric rheumatology: past, present and future.
    Ruperto N; Vesely R; Saint-Raymond A; Martini A;
    Ann Rheum Dis; 2013 Dec; 72(12):1893-6. PubMed ID: 23962457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in biomarkers for paediatric rheumatic diseases.
    Consolaro A; Varnier GC; Martini A; Ravelli A
    Nat Rev Rheumatol; 2015 May; 11(5):265-75. PubMed ID: 25512012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile idiopathic arthritis--current and future therapies.
    Kahn P
    Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric and adolescent rheumatic diseases: measures of disease activity.
    Varnier GC; Ciurtin C
    Br J Hosp Med (Lond); 2019 Jun; 80(6):338-342. PubMed ID: 31180784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives.
    Wahezi DM; Ilowite NT
    Expert Opin Pharmacother; 2013 Jun; 14(8):975-89. PubMed ID: 23528005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids in paediatric rheumatology.
    Ravelli A; Lattanzi B; Consolaro A; Martini A
    Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S148-52. PubMed ID: 22018202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.
    Berard RA; Laxer RM
    Expert Opin Biol Ther; 2013 Nov; 13(11):1623-30. PubMed ID: 24070010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heart and pediatric rheumatology.
    Vogel T; Kitcharoensakkul M; Fotis L; Baszis K
    Rheum Dis Clin North Am; 2014 Feb; 40(1):61-85. PubMed ID: 24268010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing outcome measures for paediatric rheumatic diseases.
    Brunner HI; Ravelli A
    Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):609-24. PubMed ID: 19853827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile idiopathic arthritis - an update on pharmacotherapy.
    Kahn P
    Bull NYU Hosp Jt Dis; 2011; 69(3):264-76. PubMed ID: 22035441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs.
    Ungar WJ; Costa V; Hancock-Howard R; Feldman BM; Laxer RM
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):111-9. PubMed ID: 20740607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines for prescribing and monitoring biologic therapies in juvenile idiopathic arthritis].
    Santos MJ; Fonseca JE; Canhão H; Conde M; José Vieira M; Costa L; Costa M; Salgado M; Melo Gomes JA;
    Acta Reumatol Port; 2007; 32(1):43-7. PubMed ID: 17450764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New treatments in pediatric rheumatology: effects, limits, and future developments].
    Quartier P
    Arch Pediatr; 2011 Nov; 18(11):1218-23. PubMed ID: 21963076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
    Prince FH; Twilt M; ten Cate R; van Rossum MA; Armbrust W; Hoppenreijs EP; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 May; 68(5):635-41. PubMed ID: 18413443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.
    Tynjälä P; Vähäsalo P; Tarkiainen M; Kröger L; Aalto K; Malin M; Putto-Laurila A; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2011 Sep; 70(9):1605-12. PubMed ID: 21623000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.